PT Jayamas Medica Industri Tbk (IDX:OMED)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
302.00
+6.00 (2.03%)
Apr 15, 2026, 4:13 PM WIB

IDX:OMED Income Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,063,8171,885,8221,736,9901,739,0542,226,573
Revenue Growth (YoY)
9.44%8.57%-0.12%-21.89%11.63%
Cost of Revenue
1,346,3211,261,8001,184,9901,176,0451,322,544
Gross Profit
717,496624,022552,000563,010904,030
Selling, General & Admin
326,599275,549250,002198,309168,243
Other Operating Expenses
1,1653,0161,842-7,5422,951
Operating Expenses
327,764278,564251,843190,767171,194
Operating Income
389,732345,458300,156372,243732,836
Interest Expense
-17,320-19,768-19,581-20,805-21,840
Interest & Investment Income
63,40857,00843,52014,37116,909
Currency Exchange Gain (Loss)
20,14711,9111,6546,7041,445
Other Non Operating Income (Expenses)
-556.14-460.86-341.03-403.98-328.64
EBT Excluding Unusual Items
455,410394,148325,409372,109729,020
Gain (Loss) on Sale of Assets
-480.18-121.4835.590.04179.92
Pretax Income
454,929394,026325,444372,109729,200
Income Tax Expense
85,98670,07464,46281,602158,821
Earnings From Continuing Operations
368,943323,952260,982290,507570,379
Minority Interest in Earnings
-1,994-2,279-1,622-4,725-7,687
Net Income
366,949321,673259,360285,782562,692
Net Income to Common
366,949321,673259,360285,782562,692
Net Income Growth
14.07%24.03%-9.25%-49.21%-17.92%
Shares Outstanding (Basic)
27,04127,05927,05927,05927,059
Shares Outstanding (Diluted)
27,04127,05927,05927,05927,059
Shares Change (YoY)
-0.07%----1.44%
EPS (Basic)
13.5711.899.5910.5620.80
EPS (Diluted)
13.5711.899.5910.5620.80
EPS Growth
14.15%24.03%-9.25%-49.21%-16.71%
Free Cash Flow
286,951260,196-22,03117,549422,386
Free Cash Flow Per Share
10.619.62-0.810.6515.61
Dividend Per Share
-3.5706.050-10.870
Dividend Growth
--40.99%---36.06%
Gross Margin
34.77%33.09%31.78%32.37%40.60%
Operating Margin
18.88%18.32%17.28%21.40%32.91%
Profit Margin
17.78%17.06%14.93%16.43%25.27%
Free Cash Flow Margin
13.90%13.80%-1.27%1.01%18.97%
EBITDA
444,100388,670334,660392,559752,142
EBITDA Margin
21.52%20.61%19.27%22.57%33.78%
D&A For EBITDA
54,36843,21334,50420,31719,307
EBIT
389,732345,458300,156372,243732,836
EBIT Margin
18.88%18.32%17.28%21.40%32.91%
Effective Tax Rate
18.90%17.78%19.81%21.93%21.78%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.